Gallacher Capital Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $340K | Buy |
22,000
+2,507
| +13% | +$38.8K | 0.16% | 187 |
|
|
2025
Q1 | $290K | Buy |
19,493
+1,854
| +11% | +$27.6K | 0.14% | 196 |
|
|
2024
Q4 | $234K | Buy |
17,639
+415
| +2% | +$5.5K | 0.12% | 241 |
|
|
2024
Q3 | $245K | Sell |
17,224
-141
| -0.8% | -$2.01K | 0.11% | 234 |
|
|
2024
Q2 | $225K | Buy |
17,365
+1,136
| +7% | +$14.7K | 0.12% | 230 |
|
|
2024
Q1 | $225K | Buy |
16,229
+927
| +6% | +$12.9K | 0.11% | 227 |
|
|
2023
Q4 | $218K | Sell |
15,302
-148
| -1% | -$2.11K | 0.12% | 229 |
|
|
2023
Q3 | $239K | Buy |
15,450
+220
| +1% | +$3.4K | 0.15% | 189 |
|
|
2023
Q2 | $239K | Buy |
15,230
+1,205
| +9% | +$18.9K | 0.14% | 204 |
|
|
2023
Q1 | $231K | Buy |
14,025
+2,967
| +27% | +$48.9K | 0.14% | 202 |
|
|
2022
Q4 | $173K | Buy |
+11,058
| New | +$173K | 0.1% | 222 |
|